Polymyxin B self-associated with phospholipid nanomicelles

Pharmaceutical Development and Technology

Volumn 17, Issue 6, 2012, Pages 654-660

  Brandenburg, Kenneth S ^a   Rubinstein, Israel ^b,c   Sadikot, Ruxana T ^b,c   Önyüksel, Hayat ^a,d  

^a University of Illinois at Chicago   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antibacterial; Drug delivery; Gram negative bacteria; Nanobiotechnology; Nanomedicine; Pseudomonas aeruginosa

Indexed keywords

1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE N [METHOXY (POLYETHYLENE GLYCOL) 2000]; 4 (2 HYDROXYETHYL) 1 PIPERAZINEETHANESULFONIC ACID; BIOMATERIAL; MACROGOL 2000; NANOPARTICLE; PHOSPHOLIPID; POLYMYXIN B; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BIOCOMPATIBILITY; BIODEGRADABILITY; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; DRUG DELIVERY SYSTEM; FLUORESCENCE SPECTROSCOPY; LIGHT SCATTERING; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ANTI-INFECTIVE AGENTS; DRUG CARRIERS; MICELLES; NANOMEDICINE; NANOPARTICLES; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; POLYMYXIN B; PSEUDOMONAS AERUGINOSA;

EID: 84867332093     PISSN: 10837450     EISSN: 10979867     Source Type: Journal    
DOI: 10.3109/10837450.2011.572893     Document Type: Article

References (29)

1. Okeke IN, Lamikanra A, Edelman R. Socioeconomic and behavioral factors leading to acquired bacterial resistance to antibiotics in developing countries. Emerging Infect Dis 1999;5:18-27. (Pubitemid 29124771)
2. Thomson CJ, Power E, Ruebsamen-Waigmann H, Labischinski H. Antibacterial research and development in the 21(st) century - An industry perspective of the challenges. Curr Opin Microbiol 2004;7:445-450. (Pubitemid 39297123)
3. Storm DR, Rosenthal KS, Swanson PE. Polymyxin and related peptide antibiotics. Annu Rev Biochem 1977;46:723-763. (Pubitemid 8252143)
4. Katsu T, Yoshimura S, Tsuchiya T, Fujita Y. Temperature dependence of action of polymyxin B on Escherichia coli. J Biochem 1984;95:1645-1653. (Pubitemid 14122379)
5. Bhor VM, Thomas CJ, Surolia N, Surolia A. Polymyxin B: An ode to an old antidote for endotoxic shock. Mol Biosyst 2005;1:213-222. (Pubitemid 41442431)
6. Hermsen ED, Sullivan CJ, Rotschafer JC. Polymyxins: Pharmacology, pharmacokinetics, pharmacodynamics, and clinical applications. Infect Dis Clin North Am 2003;17:545-562.
7. Zavascki AP, Goldani LZ, Cao G, Superti SV, Lutz L, Barth AL et al. Pharmacokinetics of intravenous polymyxin B in critically ill patients. Clin Infect Dis 2008;47:1298-1304.
8. Krishnadas A, Onyüksel H, Rubinstein I. Interactions of VIP, secretin and PACAP(1-38) with phospholipids: A biological paradox revisited. Curr Pharm Des 2003;9:1005-1012. (Pubitemid 36443202)
9. Ashok B, Rubinstein I, Tsueshita T, Onyüksel H. Effects of peptide molecular mass and PEG chain length on the vasoreactivity of VIP and PACAP(1-38) in pegylated phospholipid micelles. Peptides 2004;25:1253-1258. (Pubitemid 39180056)
10. Gandhi S, Tsueshita T, Onyüksel H, Chandiwala R, Rubinstein I. Interactions of human secretin with sterically stabilized phospholipid micelles amplify peptide-induced vasodilation in vivo. Peptides 2002;23:1433-1439. (Pubitemid 35223011)
11. Krishnadas A, Rubinstein I, Onyüksel H. Sterically stabilized phospholipid mixed micelles: In vitro evaluation as a novel carrier for water-insoluble drugs. Pharm Res 2003;20:297-302. (Pubitemid 36269739)
12. Ashok B, Arleth L, Hjelm RP, Rubinstein I, Onyüksel H. In vitro characterization of PEGylated phospholipid micelles for improved drug solubilization: Effects of PEG chain length and PC incorporation. J Pharm Sci 2004;93:2476-2487. (Pubitemid 39319431)
13. Koo OM, Rubinstein I, Onyuksel H. Camptothecin in sterically stabilized phospholipid nano-micelles: A novel solvent pH change solubilization method. J Nanosci Nanotechnol 2006;6:2996-3000. (Pubitemid 44579974)
14. Arleth L, Ashok B, Onyuksel H, Thiyagarajan P, Jacob J, Hjelm RP. Detailed structure of hairy mixed micelles formed by phosphatidylcholine and PEGylated phospholipids in aqueous media. Langmuir 2005;21:3279-3290. (Pubitemid 40538337)
15. Koo OM, Rubinstein I, Onyuksel H. Role of nanotechnology in targeted drug delivery and imaging: A concise review. Nanomedicine 2005;1:193-212. (Pubitemid 43963632)
16. Bakker-Woudenberg IA, Lokerse AF, ten Kate MT, Storm G. Enhanced localization of liposomes with prolonged blood circulation time in infected lung tissue. Biochim Biophys Acta 1992;1138:318-326.
17. Frantzen CB, Ingebrigtsen L, Skar M, Brandl M. Assessing the accuracy of routine photon correlation spectroscopy analysis of heterogeneous size distributions. AAPS PharmSciTech 2003;4:E36.
18. Teale FW. The ultraviolet fluorescence of proteins in neutral solution. Biochem J 1960;76:381-388.
19. Eliasson Lantz A, Jørgensen P, Poulsen E, Lindemann C, Olsson L. Determination of cell mass and polymyxin using multi-wavelength fluorescence. J Biotechnol 2006;121:544-554. (Pubitemid 43201931)
20. McAllister SM, Alpar HO, Brown MR. Antimicrobial properties of liposomal polymyxin B. J Antimicrob Chemother 1999;43: 203-210. (Pubitemid 29082444)
21. Garbuzenko O, Zalipsky S, Qazen M, Barenholz Y. Electrostatics of PEGylated micelles and liposomes containing charged and neutral lipopolymers. Langmuir 2005;21:2560-2568. (Pubitemid 40421909)
22. Uster PS, Allen TM, Daniel BE, Mendez CJ, Newman MS, Zhu GZ. Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett 1996;386:243-246. (Pubitemid 26173078)
23. Johnsson M, Hansson P, Edwards K. Spherical micelles and other self-Assembled structures in dilute aqueous mixtures of poly(ethylene glycol) lipids. J Phys Chem B 2001;105:8420-8430. (Pubitemid 35338819)
24. HsuChen CC, Feingold DS. The mechanism of polymyxin B action and selectivity toward biologic membranes. Biochemistry 1973;12:2105-2111.
25. Cajal Y, Ghanta J, Easwaran K, Surolia A, Jain MK. Specificity for the exchange of phospholipids through polymyxin B mediated intermembrane molecular contacts. Biochemistry 1996;35: 5684-5695. (Pubitemid 26143664)
26. Wiese A, Münstermann M, Gutsmann T, Lindner B, Kawahara K, Zähringer U et al. Molecular mechanisms of polymyxin B-membrane interactions: Direct correlation between surface charge density and self-Promoted transport. J Membr Biol 1998;162:127-138. (Pubitemid 28143155)
27. Israelachvili JN, ed. Intermolecular and Surface Forces with Applications to Colloidal and Biological Systems. London: Academic Press; 1991.
28. Hasham SN, Pillarisetti S. Vascular lipases, inflammation and atherosclerosis. Clin Chim Acta 2006;372:179-183. (Pubitemid 44286780)
29. Paradis ME, Badellino KO, Rader DJ, Deshaies Y, Couture P, Archer WR et al. Endothelial lipase is associated with inflammation in humans. J Lipid Res 2006;47:2808-2813. (Pubitemid 44936094)